Source: FinanzNachrichten

Menarini Silicon Biosystems.: C O R R E C T I O N -- Menarini Silicon Biosystems

In the news release, Menarini's cell based non-invasive prenatal technology demonstrates high resolution detection of fetal genomic abnormalities from a simple maternal blood draw, issued 02-Jul-2...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
CEO Avatar

Chairman & CEO

Giuseppe Giorgini

CEO Approval Rating

66/100

Read more